Younger Postmenopausal Patients With Early-Stage Breast Cancer May Be Able to Safely Omit Adjuvant Radiotherapy
December 08, 2023
December 08, 2023
SAN ANTONIO, Texas, Dec. 8 (TNSres) -- The American Association for Cancer Research posted the following news release:
* * *
Results are from a five-year follow-up; long-term study is needed
* * *
Almost all postmenopausal patients aged 50-69 years with stage I hormone receptor (HR)-positive breast cancer and low scores on a common genetic test who opted out of adjuvant radiotherapy were disease free five years after surgery, according to resul . . .
* * *
Results are from a five-year follow-up; long-term study is needed
* * *
Almost all postmenopausal patients aged 50-69 years with stage I hormone receptor (HR)-positive breast cancer and low scores on a common genetic test who opted out of adjuvant radiotherapy were disease free five years after surgery, according to resul . . .